Effects of a low-cost protocol on outcome and cost in a group practice setting

Journal of Clinical Anesthesia

Volumn 10, Issue 5, 1998, Pages 416-424

  Kirsch, Mark A ^a   Carrithers, Joe A ^a   Hagan, Robert H ^a,b   Borra, Henry M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b WESLEY MEDICAL CENTER   (United States)

Author keywords

Cholecystectomy, laparoscopic; Coronary artery bypass graft; Cost analysis; Drug costs; Lumbar laminectomy; Outcomes assessment

Indexed keywords

ANESTHETIC AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; DROPERIDOL; FENTANYL; HYDRALAZINE; INHALATION ANESTHETIC AGENT; LABETALOL; METOCLOPRAMIDE; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROMUSCULAR BLOCKING AGENT; NIFEDIPINE; NITROPRUSSIDE SODIUM; ONDANSETRON; PANCURONIUM; PETHIDINE; PROCHLORPERAZINE; PROPRANOLOL; SUXAMETHONIUM; THIOPENTAL;

ADULT; AGED; ANESTHESIST; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORONARY ARTERY BYPASS GRAFT; COST CONTROL; DRUG COST; FEMALE; GENERAL ANESTHESIA; GROUP PRACTICE; HUMAN; HYPERTENSION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LAMINECTOMY; MALE; NAUSEA; NEUROMUSCULAR BLOCKING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

AGED; ANESTHESIA RECOVERY PERIOD; ANESTHESIOLOGY; ANESTHETICS, GENERAL; ANESTHETICS, INTRAVENOUS; CASE-CONTROL STUDIES; CHOLECYSTECTOMY, LAPAROSCOPIC; CORONARY ARTERY BYPASS; COST SAVINGS; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; GROUP PRACTICE; HUMANS; HYPERTENSION; LAMINECTOMY; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NARCOTICS; NAUSEA; NEUROMUSCULAR AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); OXYGEN INHALATION THERAPY; PAIN, POSTOPERATIVE; POSTOPERATIVE COMPLICATIONS; PRIVATE PRACTICE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 0032146440     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(98)00057-9     Document Type: Article

References (19)

1. Becker KE, Carrithers J: Practical methods of cost containment in anesthesia and surgery. J Clin Anesth 1994;6:388-99.
2. Thurow LC: Medicine versus economics. N Engl J Med 1985;313: 611-4.
3. Doze VA, Shafer A, White PF: Propofol-nitrous oxide versus thiopental-isoflurane-nitrous oxide for general anesthesia. Anesthesiology 1988;69:63-71.
4. Todd MM, Warner DS, Sokoll MD, et al: A prospective, comparative trial of three anesthetics for elective supratentorial craniotomy Propofol/fentanyl, isoflurane/nitrous oxide, and fentanyl/ nitrous oxide. Anesthesiology 1993;78:1005-20.
5. Sung YF, Reiss N, Tillette T: The differential cost of anesthesia and recovery with propofol-nitrous oxide anesthesia versus thiopental sodium-isoflurane-nitrous oxide anesthesia. J Clin Anesth 1991;3:391-4.
6. Borgeat A, Wilder-Smith OH, Saiah M, Rifat K: Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 1992;74:539-41.
7. Watcha MF, Simeon RM, White PF, Stevens JL: Effect of propofol on the incidence of postoperative vomiting after strabismus surgery in pediatric patients. Anesthesiology 1991;75(2):204-9.
8. Hannallah RS, Britton JT, Schafer PG, Patel RI, Norden JM: Propofol anaesthesia in paediatric ambulatory patients: a comparison with thiopentone and halothane. Can J Anaesth 1994;41: 12-8.
9. Cotter SM, Petros AJ, Dore CJ, Barber ND, White DC: Low-flow anaesthesia. Practice, cost implications and acceptability. Anaesthesia 1991;46:1009-12.
10. Weiskopf RB, Eger EI 2d: Comparing the costs of inhaled anesthetics. Anesthesiology 1993;79:1413-8.
11. Johnstone RE, Jozefczyk KG: Costs of anesthetic drugs: experiences with a cost education trial. Anesth Analg 1994;78:766-71.
12. Grossman E, Messerli FH, Grodzocki T, Kowey P: Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328-31.
13. Mora CT, Dudek C, Torjman MC, White PF: The effects of anesthetic technique on the hemodynamic response and recovery profile in coronary revascularization patients. Anesth Analg 1995;81:900-10.
14. Quasha AL, Loeber N, Feeley TW, Ullyot DJ, Roizen MF: Postoperative respiratory care: a controlled trial of early and late extubation following coronary-artery bypass grafting. Anesthesiology 1980;52:135-41.
15. Code L, Morley PT, Ross AW: Is propofol cost-effective for day surgery patients? Anaesth Intensive Care 1991;19:201-4.
16. Korttila K, Ostman P, Faure E, et al: Randomized comparison of recovery after propofol-nitrous oxide versus thiopentone-isoflurane-nitrous oxide anaesthesia in patients undergoing ambulatory surgery. Acta Anaesthesiol Scand 1990;34:400-3.
17. Lubarsky DA, Glass PS, Ginsberg B et al: The successful implementation of pharmaceutical practice guidelines. Analysis of associated outcomes and cost savings. SWIPE Group. Systematic Withdrawal of Perioperative Expenses. Anesthesiology 1997;86: 1145-60.
18. Santill JP: Projecting future drug expenditures - 1995. Am J Health-Syst Pharm 1995;52:151-63.
19. Ramspacher S: Leading 1994 dollar volume pharmaceuticals. Hosp Pharm 1995;30:666-9.